The Healthcare Biotechnology group is led by and based at the Institute of Biotechnology.
The principal focus of our research programme over the last 40 years has been the high value - low volume sectors of pharmaceuticals, fine chemicals and diagnostics. The work is characterised by not only being highly inter- and multi-disciplinary and covering aspects of biochemistry, microbiology, chemistry, electrochemistry, physics, electronics and chemical engineering, but also covering the entire range from pure science to strategic applied science, some of which has significant commercial applications.
The principal areas of expertise are and .
We have extensive collaborations within Cambridge, in the UK and Overseas and we are open for further collaborations in all of the above mentioned areas.
Interesting facts
-
A biologic medical product, also known as a biological product, or more simply as a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, allergenic, somatic cell, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by...
-
CHI-California Healthcare Institute is a private, non-profit public policy research and advocacy organization, representing more than 250 universities, academic research centers, biotechnology and medical device companies. Founded in 1993, and based in La Jolla, California, CHI has offices in Washington, D.C., and Sacramento, California. CHI...
-
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philosophy. It also includes the study of the more commonplace questions of values ("the ethics...
Source: www.ceb.cam.ac.uk